Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide

Zhang, H., Schneider, S. E., Bray, B., Friedrich, P., Tvermoes, N., Mader, C., Whight, S., Niemi, T., Silinski, P., Picking, T., Warren, M., & Wring, S. (2007). Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide. Organic Process Research and Development, 12(1), 101 - 110.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article

The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia